Evaluation of moxifloxacin effevtiveness in wound healing

Evaluation of topical moxifloxacin effevtiveness and placebo in general Surgeries wound healing

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20181208041882N5

Enrollment

Registered

2021-10-25

Start date

2021-11-06

Completion date

Unknown

Last updated

2021-11-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Wounds from the site of general surgery.

Interventions

Intervention 1: Intervention group: Patients use moxifloxacin cream on the suture site for 5 days after surgery. In this study, 80 patients were randomized into two treatment groups (A and B). In both

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Patients who have undergone general surgery Patients over 18 years old

Exclusion criteria

Exclusion criteria: Diabetes Liver failure Renal failure Epilepsy Rheumatoid Arthritis Heart failure

Design outcomes

Primary

Measure	Time frame
Review of the Redness, Edema, Ecchymosis, Discharge, Approximation index. Timepoint: Days 0, 1, 3 and 5 after surgery. Method of measurement: Observational.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactBehrooz heydari

Yazd University of Medical Sciences

b.heydari@ssu.ac.ir+98 35 3820 3410

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026